Panobinostat Completed Phase 2 Trials for Prostate Cancer Prevention

IndicationsStatusPurposePhase
CompletedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT00667862Efficacy and Safety Study of Panobinostat in Patients With Metastatic Hormone Refractory Prostate Cancer